Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis

BACKGROUND: Newer classes of targeted drugs for moderate to severe plaque psoriasis are more effective and more expensive than older classes, posing a difficult and potentially costly decision about whether to use them as initial targeted treatments. OBJECTIVE: To estimate the clinical and economic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendrix, Nathaniel, Ollendorf, Daniel A., Chapman, Richard H., Loos, Anne, Liu, Shanshan, Kumar, Varun, Linder, Jeffrey A., Pearson, Steven D., Veenstra, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398188/
https://www.ncbi.nlm.nih.gov/pubmed/30479197
http://dx.doi.org/10.18553/jmcp.2018.24.12.1210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398188/
https://www.ncbi.nlm.nih.gov/pubmed/30479197
http://dx.doi.org/10.18553/jmcp.2018.24.12.1210

Ejemplares similares